United Orthopedic (4129) — Capital Reinvestment Ratio

Latest as of March 2026: 1.59x

United Orthopedic (4129) has a Capital Reinvestment Ratio of 1.59x as of March 2026, meaning it reinvests 2% of its operating cash flow (NT$138.91 Million) in capital expenditures (NT$221.13 Million). Check 4129 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.59x
Capex / Operating Cash Flow

Operating Cash Flow

NT$138.91 Million
TWD

Capital Expenditures

NT$221.13 Million
TWD

Data as of

Mar 2026
Most recent filing

United Orthopedic Capital Reinvestment Ratio (2015–2025)

This chart tracks United Orthopedic's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see cash flow conversion of United Orthopedic.

Annual Capital Reinvestment Ratio for United Orthopedic (2015–2025)

Year-by-year Capital Reinvestment Ratio for United Orthopedic from 2015 to 2025. See 4129 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (TWD) Capital Expenditures YoY Change
2025 0.74x NT$1.03 Billion NT$761.23 Million ▼ -9.7%
2024 0.82x NT$717.29 Million NT$589.33 Million ▼ -41.3%
2023 1.40x NT$398.43 Million NT$557.53 Million ▲ +23.5%
2022 1.13x NT$340.79 Million NT$386.21 Million ▲ +66.9%
2021 0.68x NT$334.64 Million NT$227.21 Million ▲ +41.1%
2020 0.48x NT$481.65 Million NT$231.79 Million ▼ -20.8%
2019 0.61x NT$492.45 Million NT$299.41 Million ▼ -98.0%
2018 31.12x NT$12.41 Million NT$386.17 Million ▼ -84.6%
2017 201.60x NT$2.90 Million NT$584.43 Million ▲ +9048.2%
2016 2.20x NT$179.03 Million NT$394.53 Million ▲ +167.9%
2015 0.82x NT$252.75 Million NT$207.93 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow